The global Urinary Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Urinary Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Urinary Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Urinary Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Urinary Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi S.A.
Astellas Pharma Inc.
Daiichi Sankyo Company Limited
Pfizer Inc.
Bayer AG
Allergan Plc.
Otsuka Pharmaceutical Co., Ltd.
GlaxosmithKline Plc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral
Injectables

Segment by Application
Hospital
Clinic
Home Care